PinPointe USA press releases bring you breaking news from around the world about our products, people, and technology. Check back often for updates
First Light-based Device Approved by FDA Specifically for Treatment of Toenail Fungus Westford, Mass., October 5, 2011 – Cynosure, Inc. (NASDAQ: CYNO), a leader in laser– and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced … Continue reading
September 12, 2011 – NuvoLase Inc., a Delaware corporation, announced today it has acquired from PinPointe USA all rights, assets and intellectual properties associated with the PinPointe FootLaser. Pursuant to its agreement with PinPointe USA, NuvoLase also gains … Continue reading
By Hamish Dow, originally published for Podiatry Now Magazine, June 2011.
A new modality has become available for the treatment of onychomycosis. I wish to share some results that I have achieved using the new FootLaser made by PinPointe. A new modality is certainly called for in the losing battle against Continue reading
Published in New Beauty Magazine under "What's Hot in Beauty", Summer 2011
It’s estimated that nearly 35 million Americans suffer from toe fungus, which can lead many to keep their feet under wraps. Prescription-strength and topical medicated polishes work, but now there’s a new way to treat feet. Continue reading
Published in Podiatry Today, July 2010, By Brian McCurdy, Senior Editor
Given the common prevalence of onychomycosis, the emergence of new laser devices to help treat this disease has been an intriguing development. A recently published study suggests that laser therapy may have a role in the treatment armamentarium … Continue reading
From Profiles in Excellence, published by Podiatry Management, March 2010
The London Nail Laser Clinic In the United Kingdom, Harley Street is to medicine what Fleet Street is to journalism and Downing Street is to politics. Located in the Central London borough of Westminster, Harley Street is the … Continue reading
From Podiatry Today, Vol 24, Issue 5, May, 2011
In this current environment with no new antifungal drugs having been released in years, all previous agents now being generic, a lack of sales representatives calling on podiatry and little discussion of the topic at CME meetings, has your approach to the treatment … Continue reading
